- Home
- PHAT vs HGTY Comparison
PHAT vs HGTY Comparison
Compare PHAT & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- HGTY
- Stock Information
- Founded
- PHAT 2018
- HGTY 1984
- Country
- PHAT United States
- HGTY United States
- Employees
- PHAT N/A
- HGTY N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- HGTY Specialty Insurers
- Sector
- PHAT Health Care
- HGTY Finance
- Exchange
- PHAT Nasdaq
- HGTY Nasdaq
- Market Cap
- PHAT 727.5M
- HGTY 820.4M
- IPO Year
- PHAT 2019
- HGTY N/A
- Fundamental
- Price
- PHAT $9.80
- HGTY $10.11
- Analyst Decision
- PHAT Strong Buy
- HGTY Hold
- Analyst Count
- PHAT 5
- HGTY 3
- Target Price
- PHAT $16.40
- HGTY $10.50
- AVG Volume (30 Days)
- PHAT 4.9M
- HGTY 78.4K
- Earning Date
- PHAT 08-07-2025
- HGTY 08-05-2025
- Dividend Yield
- PHAT N/A
- HGTY N/A
- EPS Growth
- PHAT N/A
- HGTY 124.60
- EPS
- PHAT N/A
- HGTY 0.20
- Revenue
- PHAT $81,859,000.00
- HGTY $1,247,923,000.00
- Revenue This Year
- PHAT $195.45
- HGTY $15.41
- Revenue Next Year
- PHAT $106.76
- HGTY $15.88
- P/E Ratio
- PHAT N/A
- HGTY $49.47
- Revenue Growth
- PHAT 3055.70
- HGTY 18.45
- 52 Week Low
- PHAT $2.21
- HGTY $8.03
- 52 Week High
- PHAT $19.71
- HGTY $12.35
- Technical
- Relative Strength Index (RSI)
- PHAT 66.25
- HGTY 63.71
- Support Level
- PHAT $8.86
- HGTY $9.33
- Resistance Level
- PHAT $11.21
- HGTY $10.23
- Average True Range (ATR)
- PHAT 1.59
- HGTY 0.26
- MACD
- PHAT -0.06
- HGTY 0.03
- Stochastic Oscillator
- PHAT 63.60
- HGTY 82.22
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.